SCHOTT PHARMA INH O.N./ DE000A3ENQ51 /
| 2024-11-08 8:16:07 AM | Chg. -0.520 | Volume | Bid9:51:56 PM | Ask9:51:56 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 28.600EUR | -1.79% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 4.39 bill.EUR | 0.51% | 28.89 |
Assets
|
2023 IFRS in mill. EUR |
||
|---|---|---|---|
| Property and Equipment | 637.8000 | ||
| Intangible Assets | 30.9400 | ||
| Long-Term Investments | 79.0500 | ||
| Fixed Assets | 763.4900 | ||
| Inventories | 138.9400 | ||
| Accounts Receivable | 156.6500 | ||
| Cash and Cash Equivalents | 24.3500 | ||
| Current Assets | 468.3300 | ||
| Total Assets | 1,231.8200 | ||
Liabilities
|
2023 IFRS in mill. EUR |
||
|---|---|---|---|
| Accounts Payable | 60.5200 | ||
| Long-term debt | - | ||
| Liabilities to Banks | - | ||
| Provisions | 58.4000 | ||
| Liabilities | 539.6400 | ||
| Share Capital | - | ||
| Total Equity | 690.4300 | ||
| Minority Interests | 1.7400 | ||
| Total liabilities equity | 1,231.8200 | ||
Income Statement
|
2023 IFRS in mill. EUR |
||
|---|---|---|---|
| Revenues | 898.6000 | ||
| Depreciation (total) | - | ||
| Operating Result | 192.3800 | ||
| Interest Income | -2.0300 | ||
| Income Before Taxes | - | ||
| Income Taxes | 33.8600 | ||
| Minority Interests Profit | .0920 | ||
| Net Income | 151.8400 | ||
Per Share
Cash Flow
|
2023 IFRS in mill. EUR |
||
|---|---|---|---|
| Cash Flow from Operating Activities | 181.6500 | ||
| Cash Flow from Investing Activities | -171.4100 | ||
| Cash Flow from Financing | -11.3900 | ||
| Decrease / Increase in Cash | - | ||
| Employees | 4,646 | ||
